Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oestrogens and dementia.

V W Henderson1

  • 1Department of Neurology, University of Southern California School of Medicine, Los Angeles 90089, USA.

Novartis Foundation Symposium
|August 31, 2000
PubMed
Summary
This summary is machine-generated.

Postmenopausal oestrogen therapy may reduce Alzheimer

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma pTau217 as a Prognostic, Monitoring, and Risk-Stratification Biomarker of Clinical Progression in Lewy Body Disease.

medRxiv : the preprint server for health sciences·2026
Same author

Preadmission use of glucocorticoids and risk of cardiovascular events in patients with ischemic stroke.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Progesterone and human cognition.

Climacteric : the journal of the International Menopause Society·2018
Same author

Comorbidity and the increased mortality after hospitalization for stroke: a population-based cohort study.

Journal of thrombosis and haemostasis : JTH·2017
Same author

PO-06 - Cancer and the risk of venous thromboembolism in stroke patients.

Thrombosis research·2016
Same author

Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis.

Climacteric : the journal of the International Menopause Society·2015

Area of Science:

  • Neuroscience
  • Endocrinology
  • Gerontology

Background:

  • Declining oestrogen levels post-menopause may influence Alzheimer's disease (AD) and dementia risk.
  • Oestrogen has neurotrophic, neuroprotective, and neurotransmitter-modulating effects.
  • Oestrogen impacts proteins involved in AD pathogenesis.

Purpose of the Study:

  • To review the evidence on the relationship between postmenopausal oestrogen therapy and dementia, particularly Alzheimer's disease.
  • To assess the potential of oestrogen for AD primary prevention and symptom management.

Main Methods:

  • Review of 14 case-control and cohort studies (post-1990) on oestrogen therapy and AD risk.
  • Examination of limited interventional trial data on oestrogen's effect on cognitive function in AD patients.

Related Experiment Videos

Main Results:

  • Most epidemiological studies suggest oestrogen therapy is associated with approximately a 50% reduced risk of Alzheimer's disease.
  • Limited data exist on oestrogen's role in other dementia types.
  • Small trials show no compelling evidence that short-term oestrogen monotherapy substantially improves dementia symptoms.

Conclusions:

  • Oestrogen's potential role in reducing Alzheimer's disease risk is biologically plausible.
  • Epidemiological data predominantly suggest a protective effect of oestrogen therapy.
  • Further well-designed randomized controlled trials are needed to confirm oestrogen's efficacy for primary prevention of Alzheimer's disease.